RLMD Competitors & Alternatives

Compare Relmada Therapeutics Inc with similar stocks in the same industry

Biotechnology

RLMD

Main Stock
$3.60
Tradestie Score
48
Market Cap
$71.69M
Analyst Upside
+198.6%

Top Competitors

232 stocks in Biotechnology
Company Price Market Cap P/E Score Action
MLTX MoonLake Immunotherapeutics Class A Ordinary Shares
$11.41
$448.32M - 51 Compare
AUTL Autolus Therapeutics plc American Depositary Share
$1.78
$444.46M - 63 Compare
ATXS Astria Therapeutics, Inc. Common Stock
$12.58
$425.52M - 54 Compare
ALMS Alumis Inc. Common Stock
$6.85
$422.50M - 55 Compare
FDMT 4D Molecular Therapeutics, Inc. Common Stock
$13.67
$407.71M - 52 Compare
DSGN Design Therapeutics, Inc. Common Stock
$12.34
$386.68M - 73 Compare
AURA Aura Biosciences, Inc. Common Stock
$6.09
$382.04M - 61 Compare
DRTS Alpha Tau Medical Ltd. Ordinary Shares
$14.77
$371.64M - 51 Compare
CAPR Capricor Therapeutics Inc
$8.95
$357.51M - 40 Compare
CGEM Cullinan Therapeutics, Inc. Common Stock
$15.51
$354.45M - 61 Compare

Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)

232 stocks in this industry